Please login to the form below

Not currently logged in
Email:
Password:

CASPIAN phase 3 trial

This page shows the latest CASPIAN phase 3 trial news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients

AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients

The CASPIAN phase 3 trial for the monoclonal antibody met its primary survival endpoint in June 2019, but the new analysis confirms that the survival benefit remains for more than three ... CASPIAN principal investigator.

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...